Smart Technology Facilitated Patient-centered Venous Thromboembolism Management

Launched by NAVY GENERAL HOSPITAL, BEIJING · Apr 1, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring how smart technologies, like wearable devices and mobile apps, can help manage a condition called venous thromboembolism (VTE), which involves blood clots that can be dangerous if not treated properly. The main goal is to see if using a mobile app designed for VTE management can improve care for patients at high risk of developing blood clots. By doing this, researchers hope to make it easier for patients to receive the best possible medical support, no matter where they live.

To participate in this trial, individuals must be at least 18 years old and be identified as at high risk for blood clots when they are discharged from the hospital. This includes people who have certain scores indicating their risk levels. However, those currently diagnosed with a blood clot, pregnant or breastfeeding, or unable to use smart devices will not be included. Participants can expect to engage with the mobile app and receive guidance on preventing blood clots, contributing to important research that could improve patient care in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Inpatients ≥18 years of age at admission;
• • At high-risk of VTE at discharge: Padua score ≥4 for medical patients and Caprini score ≥5 for surgical patients;
• • Signed informed consent.
• Exclusion Criteria:
• • Diagnosis of VTE at discharge;
• • Mental disorder or combination of other serious diseases leading to incapacity for independent living;
• • Inability to use smartphones, computer tablets and other smart devices;
• • Being pregnant or breastfeeding;
• • Have participated in similar trials or are undergoing other clinical trials.